blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0439077

EP0439077 - Synthetic peptide compositions with immunoreactivities to antibodies to HTLV [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.03.2001
Database last updated on 05.10.2024
Most recent event   Tooltip07.12.2007Lapse of the patent in a contracting state
New state(s): IT		published on 09.01.2008  [2008/02]
Applicant(s)For all designated states
United Biomedical Inc.
2 Nevada Drive Lake Success
New York 11042 / US
[N/P]
Former [1991/31]For all designated states
United Biomedical Inc.
2 Nevada Drive
Lake Success New York 11042 / US
Inventor(s)01 / Chang Yi Wang
156 Hill Park Avenue Great Neck
New York 11021 / US
[1991/31]
Representative(s)Vogeser, Werner, et al
Hansmann & Vogeser
Patent- und Rechtsanwälte
Albert-Rosshaupter-Strasse 65
81369 München / DE
[N/P]
Former [1994/11]Vogeser, Werner, Dipl.-Ing., et al
Patent- und Rechtsanwälte Hansmann, Vogeser, Dr. Boecker, Alber, Dr. Strych, Liedl Albert-Rosshaupter-Strasse 65
D-81369 München / DE
Former [1991/31]Vogeser, Werner, Dipl.-Ing.
Patent- und Rechtsanwälte, Hansmann Vogeser Dr. Boecker Alber Dr. Strych, Albert-Rosshaupter-Strasse 65
D-81369 München / DE
Application number, filing date91100616.118.01.1991
[1991/31]
Priority number, dateUS1990046929124.01.1990         Original published format: US 469291
[1991/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0439077
Date:31.07.1991
Language:EN
[1991/31]
Type: A3 Search report 
No.:EP0439077
Date:10.06.1992
Language:EN
[1992/24]
Type: B1 Patent specification 
No.:EP0439077
Date:17.05.2000
Language:EN
[2000/20]
Search report(s)(Supplementary) European search report - dispatched on:EP24.04.1992
ClassificationIPC:C07K14/15, G01N33/569
[2000/01]
CPC:
C07K14/005 (EP); C12N2740/14022 (EP)
Former IPC [1991/31]C07K7/10, C07K7/08, G01N33/569
Designated contracting statesBE,   DE,   FR,   GB,   IT,   NL,   SE [1991/31]
TitleGerman:Immunaktive Peptidzusammensetzung gegen HTLV-Antikörper[1991/31]
English:Synthetic peptide compositions with immunoreactivities to antibodies to HTLV[1991/31]
French:Composition peptidique ayant une activité immunologique contre des anticorps contre HTLV[1991/31]
Examination procedure10.12.1992Examination requested  [1993/05]
28.11.1994Despatch of a communication from the examining division (Time limit: M04)
10.04.1995Reply to a communication from the examining division
24.04.1995Despatch of a communication from the examining division (Time limit: M06)
26.10.1995Reply to a communication from the examining division
27.11.1995Despatch of a communication from the examining division (Time limit: M07)
05.07.1996Reply to a communication from the examining division
17.07.1996Despatch of a communication from the examining division (Time limit: M04)
27.11.1996Reply to a communication from the examining division
16.05.1997Despatch of a communication from the examining division (Time limit: M04)
26.09.1997Reply to a communication from the examining division
20.03.1998Despatch of a communication from the examining division (Time limit: M08)
30.11.1998Reply to a communication from the examining division
21.12.1998Despatch of a communication from the examining division (Time limit: M04)
30.04.1999Reply to a communication from the examining division
05.07.1999Despatch of communication of intention to grant (Approval: Yes)
17.11.1999Communication of intention to grant the patent
02.02.2000Fee for grant paid
02.02.2000Fee for publishing/printing paid
Opposition(s)20.02.2001No opposition filed within time limit [2001/19]
Fees paidRenewal fee
14.12.1992Renewal fee patent year 03
22.12.1993Renewal fee patent year 04
27.12.1994Renewal fee patent year 05
27.12.1995Renewal fee patent year 06
18.12.1996Renewal fee patent year 07
26.01.1998Renewal fee patent year 08
05.01.1999Renewal fee patent year 09
05.01.2000Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE17.05.2000
FR17.05.2000
IT17.05.2000
NL17.05.2000
SE17.08.2000
DE18.08.2000
[2008/02]
Former [2006/14]BE17.05.2000
FR17.05.2000
NL17.05.2000
SE17.08.2000
DE18.08.2000
Former [2003/07]BE17.05.2000
NL17.05.2000
SE17.08.2000
DE18.08.2000
FR13.10.2000
Former [2002/13]BE17.05.2000
SE17.08.2000
DE18.08.2000
FR13.10.2000
Former [2001/27]BE17.05.2000
SE17.08.2000
FR13.10.2000
Former [2001/24]BE17.05.2000
FR13.10.2000
Former [2001/11]BE17.05.2000
Documents cited:Search[X]US4833071  ;
 [X]WO8908664  ;
 [XP]WO9010231  ;
 [XP]WO9015820
 [X]  - JOURNAL OF IMMUNOLOGY vol. 142, no. 3, 1989, BALTIMORE pages 971 - 978; PALKER ET AL: 'Mapping of immunogenic regions of human T cell leukemia virus type 1 ( HTLV-1 ) gp46 envelope glycoproteins with env-coded synthetic peptides and a monoclonal antibody to gp46'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.